(i) – discussion of IFRS 3 recognition of intangible assets and information provided
 about different intangible assets so that investor adjustments can be made 3
 – discussion of cost or revaluation under IAS 38 and differences 2
 – discussion of differences in treatment of R&D and development expenditure 2